Genomics Unmuted: Genetic profiling and polygenic risk score performance evaluation in the multi-ethnic population of the Kahn Sagol Maccabi Biobank

Coupling rich electronic health record data with the ability to sequence patients of interest is key to the identification of molecular signatures of specific populations and their application to drug discovery. In our latest webinar, Olivia Sabik from Valo Health shares how their collaboration with Kahn-Sagol-Maccabi (KSM), Maccabi Healthcare Services' Research and Innovation Center, offers an unparalleled opportunity to identify patient cohorts using deep longitudinal data. She discusses how the unique population history of these cohorts provides an opportunity for groundbreaking discoveries and how Valo Health is leveraging the Gencove platform to accelerate this discovery.